Cyclerion Therapeutics, Inc.
CYCN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,057 | -$12,593 | -$18,246 | -$51,647 |
| Dep. & Amort. | $0 | $0 | $65 | $472 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $625 | $0 | $0 | $9,611 |
| Change in WC | -$1,538 | -$4,601 | -$2,850 | $1,408 |
| Other Non-Cash | -$363 | -$4,051 | -$19,580 | $3,639 |
| Operating Cash Flow | -$4,333 | -$21,245 | -$40,611 | -$36,517 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$7 |
| Net Acquisitions | $0 | $10,402 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $1,464 |
| Investing Cash Flow | $0 | $10,402 | $0 | $1,457 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $5,024 | $29 | $30,503 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $282 |
| Financing Cash Flow | $0 | $5,024 | $29 | $30,785 |
| Forex Effect | -$6 | $8 | $3 | $4 |
| Net Chg. in Cash | -$4,339 | -$5,811 | -$40,579 | -$4,271 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,571 | $13,382 | $53,961 | $58,232 |
| End Cash | $3,232 | $7,571 | $13,382 | $53,961 |
| Free Cash Flow | -$4,333 | -$21,245 | -$40,611 | -$36,524 |